liams Center Plastic Surgery Specialists, and nationally recognized plastic surgeon pioneered this breakthrough
Vbeam treatment. "Anytime you penetrate the skin there is a potential for bruising and we find that it is the bruising which occurs after many of these procedures that prevents patients from getting out into the public. It is extremely difficult to cover these unsightly marks with make-up and bruising can last for a number of weeks," said Dr. Williams. Dr. Williams continued, "After just one treatment with the
Vbeam, our patients experience dramatic clearance of the injured blood vessels. This treatment is a significant differentiator to our practice and we are excited to finally be able to offer our patients a safe and easy treatment of bruising that works!"
Roy G. Geronemus, M.D., Director, Laser & Skin Surgery Center of New York, commented, "There are millions of surgical and injectable procedures performed every year which often have bruising as a side effect that can last up to two weeks." Dr. Geronemus continued, "This is a significant new use for the Vbeam which was already our 'workhorse' laser because of its efficacy and safety profile for a wide variety of applications including skin rejuvenation, the treatment of rosacea, acne, diffuse redness, scars and more."
For more information and to request copies of the studies, visit www.candelalaser.com or call 800-733-8550, ext. 247.
About CANDELA: Candela Corporation manufactures and distributes innovative clinical solutions that enable physicians, surgeons, and personal care practitioners to treat selected cosmetic and medical conditions using lasers, aesthetic laser systems, and other advanced technologies. Founded near Boston in 1970, Candela markets and services its products in 86 countries from offices and distribu
'/>"/>
SOURCE Candela Corporation Copyright©2009 PR Newswire. All rights reserved | |
Page: 1 2 3 Related medicine news :1.
Gene Studies of Male-Female Differences Often Flawed2.
Two studies published in the Lancet3.
Study of Studies Finds No Risk to Children From Phthalates in Toys4.
Just Completed Studies Reveal Impact of New Medicare Reimbursement Regulations5.
Studies Prove Exercise Can Heal the Body Mind and Soul6.
Studies Shed New Light on Breast Cancer, Treatment7.
Multi-Year Compendium of Pharmaceutical Case Studies Available from Best Practices, LLC8.
Genomic Health Announces Multiple Studies on Oncotype DX(TM) Presented at 2007 American Society of Clinical Oncology (ASCO) Breast Cancer Symposium9.
Best Practice Database: Complimentary Excerpt of Three Sales Force Excellence Studies10.
Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs11.
NIH awards Einstein multimillion dollar grant to extend studies of exceptional longevity